Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2475.3 and 2549.2
| Intraday Target 1 | 2419.6 |
| Intraday Target 2 | 2457.1 |
| Intraday Target 3 | 2493.5 |
| Intraday Target 4 | 2531 |
| Intraday Target 5 | 2567.4 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 23 April 2026 | 2494.60 (1.18%) | 2480.00 | 2456.00 - 2529.90 | 1.5035 times | Wed 22 April 2026 | 2465.60 (1.57%) | 2420.20 | 2397.10 - 2496.00 | 1.259 times | Tue 21 April 2026 | 2427.40 (-0.1%) | 2429.90 | 2420.10 - 2450.00 | 0.4155 times | Mon 20 April 2026 | 2429.90 (-0.98%) | 2465.00 | 2410.90 - 2466.10 | 0.7721 times | Fri 17 April 2026 | 2453.90 (1.41%) | 2419.80 | 2410.00 - 2465.40 | 0.9176 times | Thu 16 April 2026 | 2419.80 (0.61%) | 2417.20 | 2391.60 - 2441.60 | 0.736 times | Wed 15 April 2026 | 2405.20 (-0.37%) | 2430.00 | 2391.00 - 2439.30 | 1.3121 times | Mon 13 April 2026 | 2414.20 (0.84%) | 2370.10 | 2341.20 - 2468.80 | 1.3691 times | Fri 10 April 2026 | 2394.00 (1.45%) | 2359.70 | 2357.00 - 2431.80 | 1.2079 times | Thu 09 April 2026 | 2359.70 (0.23%) | 2354.30 | 2345.00 - 2374.30 | 0.5072 times | Wed 08 April 2026 | 2354.30 (0.9%) | 2377.00 | 2348.00 - 2396.90 | 1.2146 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2445.85 and 2578.65
| Weekly Target 1 | 2341.07 |
| Weekly Target 2 | 2417.83 |
| Weekly Target 3 | 2473.8666666667 |
| Weekly Target 4 | 2550.63 |
| Weekly Target 5 | 2606.67 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 23 April 2026 | 2494.60 (1.66%) | 2465.00 | 2397.10 - 2529.90 | 0.7852 times | Fri 17 April 2026 | 2453.90 (2.5%) | 2370.10 | 2341.20 - 2468.80 | 0.8616 times | Fri 10 April 2026 | 2394.00 (3.57%) | 2307.00 | 2267.80 - 2431.80 | 0.9776 times | Thu 02 April 2026 | 2311.50 (2.3%) | 2259.50 | 2217.60 - 2401.90 | 1.3195 times | Fri 27 March 2026 | 2259.50 (-5.25%) | 2353.40 | 2255.10 - 2364.90 | 1.0734 times | Fri 20 March 2026 | 2384.80 (-1.63%) | 2413.00 | 2362.50 - 2472.00 | 0.7822 times | Fri 13 March 2026 | 2424.30 (-3.69%) | 2500.00 | 2397.70 - 2554.00 | 1.0501 times | Fri 06 March 2026 | 2517.30 (-2.11%) | 2520.00 | 2450.10 - 2581.60 | 1.0153 times | Fri 27 February 2026 | 2571.60 (-0.97%) | 2616.80 | 2566.00 - 2668.80 | 1.0136 times | Fri 20 February 2026 | 2596.90 (0.1%) | 2590.00 | 2558.10 - 2644.00 | 1.1215 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 2.9071 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2378.25 and 2646.25
| Monthly Target 1 | 2160.8 |
| Monthly Target 2 | 2327.7 |
| Monthly Target 3 | 2428.8 |
| Monthly Target 4 | 2595.7 |
| Monthly Target 5 | 2696.8 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 23 April 2026 | 2494.60 (9.27%) | 2305.00 | 2261.90 - 2529.90 | 0.4884 times | Mon 30 March 2026 | 2283.00 (-11.22%) | 2520.00 | 2217.60 - 2581.60 | 0.6445 times | Fri 27 February 2026 | 2571.60 (7.08%) | 2421.40 | 2342.10 - 2719.80 | 0.9405 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.8401 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 1.373 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 1.1452 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.7436 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 1.1846 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.6393 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 1.0009 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 2.0026 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2356.1 and 2858.3
| Yearly Target 1 | 1975.13 |
| Yearly Target 2 | 2234.87 |
| Yearly Target 3 | 2477.3333333333 |
| Yearly Target 4 | 2737.07 |
| Yearly Target 5 | 2979.53 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 23 April 2026 | 2494.60 (0.85%) | 2476.00 | 2217.60 - 2719.80 | 0.2651 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6414 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2457 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2484 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7251 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9672 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0793 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4617 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2348 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1313 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1316 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2423.76 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be moving in a flat line. No recent bulk deals happened to affect the stock trend.
Munafa value: 70 as on Thu 23 April 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2370 and price is deviating by 66 points
Upper Bollinger band is at 2501 and lower is at 2239, while middle bands are at 2304 and 2436
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of GlaxosmithklinePharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2432.19 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2454.28 |
| 12 day DMA | 2412.67 |
| 20 day DMA | 2369.59 |
| 35 day DMA | 2412.31 |
| 50 day DMA | 2470.22 |
| 100 day DMA | 2465.75 |
| 150 day DMA | 2531.52 |
| 200 day DMA | 2639.89 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2456.42 | 2437.34 | 2423.21 |
| 12 day EMA | 2423.74 | 2410.86 | 2400.91 |
| 20 day EMA | 2413.6 | 2405.08 | 2398.71 |
| 35 day EMA | 2431.67 | 2427.97 | 2425.75 |
| 50 day EMA | 2464.74 | 2463.52 | 2463.44 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2454.28 | 2439.32 | 2427.24 |
| 12 day SMA | 2412.67 | 2400.33 | 2387.49 |
| 20 day SMA | 2369.59 | 2364.1 | 2359.65 |
| 35 day SMA | 2412.31 | 2416.07 | 2421.41 |
| 50 day SMA | 2470.22 | 2469.22 | 2468.05 |
| 100 day SMA | 2465.75 | 2465.67 | 2465.78 |
| 150 day SMA | 2531.52 | 2533.98 | 2536.46 |
| 200 day SMA | 2639.89 | 2644.18 | 2648.79 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 60.27 and PE is: 41.39
Last quarter profit: (December 2025 quarter) 295.62 crores (22.82%)
Debt: 35.71 in crores
Market capitalization: 38277.29
EPS is 56.39 and PE is: 44.24
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
